Stock Analysis, Dividends, Split History

UVE / Universal Insurance Holdings, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price45.30
Volume197,800.00
Market Cap ($M)1,577.96
Enterprise Value ($M)1,279.01
Book Value ($M)492.07
Book Value / Share14.11
Price / Book3.21
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Shares Outstanding 34,863,056
Preferred Stock Shares Outstanding 10,000
Common Stock Shares Outstanding 34,735,000
Scoring Models
Piotroski F-Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.24
Return on Assets (ROA)0.10
Return on Equity (ROE)0.29
Balance Sheet (mrq) ($M)
Assets1,711.28
Liabilities1,219.20
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Insurance Services Revenue0.00
Revenues751,916,000.00
Net Income106.94
Earnings Per Share Basic3.07
Earnings Per Share Diluted2.99
Cash Flow Statement (mra) ($M)
Cash From Operations245.01
Cash from Investing-85.71
Cash from Financing245.01
Identifiers and Descriptors
CUSIP91359V107
Central Index Key (CIK)891166
Related CUSIPS
91359V907 91359V957

Split History

Stock splits are used by Universal Insurance Holdings, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Universal Insurance: The Beast Is Unleashed

2018-07-30 seekingalpha
Growth was off the charts: Revenue increased over 13% and EPS growth nearly reached 60%. Book value compounded at ~20%. Return on Equity nearly reached 40%.

Universal Insurance Holdings: An Emerging Dividend Growth Machine

2018-07-09 seekingalpha
UVE enjoys a lengthy growth runway and displayed the strength of its reinsurance program in the aftermath of hurricane Irma.

4 Notable Dividend Increases From the Past Week

2018-06-04 investorplace
The S&P 500 Index edged higher last week after investors reacted positively to another strong report on the U.S. labor market. With corporate profits heading higher, several companies rewarded shareholders with news of fresh dividend raises. (12-0)

Universal Expects Mid-Year Reinsurance Renewal Pricing To Be Lower

2018-05-01 seekingalpha
The mid-year reinsurance renewal at June 1st is expected to yield pricing that is lower than last year for Florida-headquartered primary insurance company Universal Insurance Holdings (NYSEMKT:UVE), which expects to be able to keep its retention static, while buying more coverage at comparable or lower rates. (9-0)

BRIEF-Universal Insurance CEO Sean Downes's FY 2017 Total Compensation Was $19.3 Million

2018-04-27 reuters
* UNIVERSAL INSURANCE HOLDINGS INC - CEO SEAN DOWNES'S FY 2017 TOTAL COMPENSATION WAS $19.3 MILLION VERSUS $16.3 MILLION IN FY 2016 - SEC FILING Source text for Eikon: (bit.ly/2KkM5RB) Further company coverage: (9-1)

Silicon Investor Message Boards

This table lists all message boards related to UVE / Universal Insurance Holdings, Inc. on message board site Silicon Investor.

Clinuvel Pharmaceuticals Ltd Clinuvel Pharmaceuticals Ltd Clinuvel Pharmaceuticals Ltd Ballad Ent.;BDC.Vancouver Ballad Ent.;BDC.Vancouver Ballad Ent.;BDC.Vancouver
Defensive Driving and Emergency Maneuvers Defensive Driving and Emergency Maneuvers Defensive Driving and Emergency Maneuvers VANCOUVER 2010 OLYMPICS BOONDOGGLE THREAD VANCOUVER 2010 OLYMPICS BOONDOGGLE THREAD VANCOUVER 2010 OLYMPICS BOONDOGGLE THREAD
Nuvelo(NUVO) Nuvelo(NUVO) Nuvelo(NUVO) REGI U.S. (OTC RGUS) Reg Technologies, (Vancouver: RRE) REGI U.S. (OTC RGUS) Reg Technologies, (Vancouver: RRE) REGI U.S. (OTC RGUS) Reg Technologies, (Vancouver: RRE)
Zappa Resources ZPA vancouver Zappa Resources ZPA vancouver Zappa Resources ZPA vancouver Nuvelo (Nasdaq: NUVO) Nuvelo (Nasdaq: NUVO) Nuvelo (Nasdaq: NUVO)
CRTM (Curtis Mathes) aka UVEW (Uniview) CRTM (Curtis Mathes) aka UVEW (Uniview) CRTM (Curtis Mathes) aka UVEW (Uniview) uniView Technologies - UVEW uniView Technologies - UVEW uniView Technologies - UVEW
CUSIP: 91359V107